{"id":"W2143439165","doi":"10.1186/ar2859","title":"Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial","year":2009,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Rheumatoid arthritis; Rheumatology; Methotrexate; Internal medicine; Quality of life (healthcare); Physical therapy; Arthritis; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004372476,0.001102235,0.004010516,0.0004617645,0.00032186,0.001181688,0.0009408905,0.001386493,0.004130446],"category_scores_gemma":[0.003537283,0.000485336,0.00289033,0.0004448245,0.000775857,0.0007825926,0.0004100681,0.001702307,0.0003914325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004458004,"about_ca_system_score_gemma":0.0008808732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004761672,"about_ca_topic_score_gemma":0.0009586863,"domain_scores_codex":[0.9984317,0.0009492624,0.0001494014,0.0002177682,0.0001340396,0.0001178018],"domain_scores_gemma":[0.9972081,0.001104816,0.001168758,0.0001462456,0.0001219803,0.0002500643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9535707,0.002790149,0.002440697,0.003771234,0.004000737,0.00005911002,0.00006123676,0.0006079148,0.001608812,0.0001121854,0.0006620322,0.03031505],"study_design_scores_gemma":[0.9422485,0.04739258,0.005896757,0.0002386244,0.002815659,0.00006794622,0.00002152039,0.0003581833,0.0002948962,0.0001135005,0.0005294042,0.00002245825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9564247,0.03800571,0.0006111216,0.000739831,0.0003860406,0.001557772,0.001075038,0.00009089733,0.001108892],"genre_scores_gemma":[0.9787335,0.0121352,0.002263178,0.0007415109,0.0007510061,0.003294374,0.001048148,0.00001758575,0.00101554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004372476,"threshold_uncertainty_score":0.02312416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0424838357597094,"score_gpt":0.3419703894465726,"score_spread":0.2994865536868632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}